Pasternak Jeffrey J, Atkinson John L D, Kasperbauer Jan L, Lanier William L
Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
J Neurosurg Anesthesiol. 2004 Jul;16(3):189-95. doi: 10.1097/00008506-200407000-00002.
Patients undergoing transsphenoidal pituitary surgery may experience hypertensive episodes during the intranasal injection of vasoconstrictor-supplemented local anesthetics or emergence from general anesthesia. The present research characterized the blood pressure responses during transsphenoidal surgery and tested the hypothesis that the underlying pituitary disease influences the incidence and magnitude of the blood pressure responses. The records of 100 patients were retrospectively reviewed. All had direct blood pressure measurements recorded using a computer-based anesthesia recording system. Mean age was 49 +/- 17 years (+/- SD) and 52% were male. Blood pressure increased by 60 +/- 37 mm Hg systolic and 23 +/- 22 mm Hg diastolic with intranasal injection and 42 +/- 24 mm Hg systolic and 23 +/- 16 mm Hg diastolic during emergence from general anesthesia. Systolic blood pressure increased by greater than 50% in 58% of patients following intranasal injection and in 33% of patients upon emergence from anesthesia. Blood pressure responses did not differ with respect to endocrinopathy type (Cushing's disease, acromegaly, or other pathology), gender, age, surgeon, history of prior transsphenoidal surgery, history of either hypertension or diabetes, or preoperative use of either beta-adrenergic or calcium channel-blocking drugs. There was poor correlation between the epinephrine dose injected (range 30-220 microg) and systolic blood pressure response (r = 0.24; r2 = 0.06; P = 0.031). Blood pressure increases were not associated with cardiac arrhythmias, persistent myocardial ischemia, or myocardial infarction. The authors conclude that in transsphenoidal hypophysectomy patients, large blood pressure increases are common with intranasal injection and upon awakening from general anesthesia. However, the authors were not able to find a variable that might enable the prediction of which patients are most likely to experience the most intense blood pressure elevations.
接受经蝶窦垂体手术的患者在鼻内注射含血管收缩剂的局部麻醉剂期间或全身麻醉苏醒时可能会出现高血压发作。本研究描述了经蝶窦手术期间的血压反应,并检验了潜在垂体疾病会影响血压反应的发生率和幅度这一假设。对100例患者的记录进行了回顾性分析。所有患者均使用基于计算机的麻醉记录系统记录了直接血压测量值。平均年龄为49±17岁(±标准差),男性占52%。鼻内注射时收缩压升高60±37 mmHg,舒张压升高23±22 mmHg;全身麻醉苏醒时收缩压升高42±24 mmHg,舒张压升高23±16 mmHg。58%的患者在鼻内注射后收缩压升高超过50%,33%的患者在麻醉苏醒时收缩压升高超过50%。血压反应在内分泌疾病类型(库欣病、肢端肥大症或其他病理情况)、性别、年龄、手术医生、既往经蝶窦手术史、高血压或糖尿病史以及术前使用β-肾上腺素能或钙通道阻滞剂方面无差异。注射肾上腺素剂量(范围为30 - 220微克)与收缩压反应之间的相关性较差(r = 0.24;r2 = 0.06;P = 0.031)。血压升高与心律失常、持续性心肌缺血或心肌梗死无关。作者得出结论,在经蝶窦垂体切除术患者中,鼻内注射和全身麻醉苏醒时常见大幅血压升高。然而,作者未能找到一个能够预测哪些患者最有可能经历最强烈血压升高的变量。